Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Electra Therapeutics, Inc. (ETRA), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-3.25
P/B ratioShare price divided by book value per share.
0.00
P/S ratioMarket value divided by annual revenue.
0.00
EV / RevenueEnterprise value against annual revenue.
0.00
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
0.00%
Price / free cash flowMarket value divided by free cash flow.
0.00
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
0.00%
Operating marginRevenue left after operating costs.
0.00%
Net marginRevenue left after every cost, including tax and interest.
0.00%
Return on equityProfit as a percentage of shareholders’ equity.
0.00%
Return on assetsProfit as a percentage of total assets.
0.00%
Return on capital employedOperating profit against the capital the business uses.
0.00%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
7.37
Quick ratioThe same, excluding inventory.
7.19
Debt to equityTotal borrowings against shareholders’ equity.
0.02
Interest coverageHow many times operating profit covers the interest bill.
0.00
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-2.78
Book value per shareShareholders’ equity divided by shares outstanding.
$0.00
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$184.76M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Electra Therapeutics, Inc. (ETRA) statistics — frequently asked questions
What is Electra Therapeutics, Inc.'s P/E ratio?
Electra Therapeutics, Inc. (ETRA) trades on a price-to-earnings ratio of -3.25. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
How much debt does Electra Therapeutics, Inc. carry?
Electra Therapeutics, Inc. (ETRA) has a debt-to-equity ratio of 0.02, which compares total borrowings with shareholders' equity.